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Abstract
Mutations of the monocarboxylate transporter 8 (MCT8) cause a severe X-linked intellectual deficit and neurological
impairment. MCT8 is a specific thyroid hormone (T4 and T3) transporter and the patients also present unusual abnormalities
in the serum profile of thyroid hormone concentrations due to altered secretion and metabolism of T4 and T3. Given the role
of thyroid hormones in brain development, it is thought that the neurological impairment is due to restricted transport of
thyroid hormones to the target neurons. In this work we have investigated cerebral metabolism in mice with Mct8
deficiency. Adult male mice were infused for 30 minutes with (1-13C) glucose and brain extracts prepared and analyzed by
13C nuclear magnetic resonance spectroscopy. Genetic inactivation of Mct8 resulted in increased oxidative metabolism as
reflected by increased glutamate C4 enrichment, and of glutamatergic and GABAergic neurotransmissions as observed by
the increases in glutamine C4 and GABA C2 enrichments, respectively. These changes were distinct to those produced by
hypothyroidism or hyperthyroidism. Similar increments in glutamate C4 enrichment and GABAergic neurotransmission were
observed in the combined inactivation of Mct8 and D2, indicating that the increased neurotransmission and metabolic
activity were not due to increased production of cerebral T3 by the D2-encoded type 2 deiodinase. In conclusion, Mct8
deficiency has important metabolic consequences in the brain that could not be correlated with deficiency or excess of
thyroid hormone supply to the brain during adulthood.
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Introduction
Thyroid hormones [3,5,3’,5’-tetraiodothyronine (T4) and 3,3’,5-
triiodothyronine (T3)] play an important role in brain develop-
ment and function [1,2]. Thyroid hormones uptake by the target
cells is facilitated by several forms of plasma membrane
transporters [3]. The monocarboxylate transporter 8 (MCT8,
SLC16A2) is very specific for the transport of T4 and T3 [4], and
plays an essential role in their uptake by the brain. MCT8 is
expressed in the blood-brain barrier (BBB), the choroid plexuses
and the plasma membrane of neural cells [5]. MCT8 gene
mutations cause an X-linked syndrome combining severe neuro-
developmental impairment and abnormal distribution and me-
tabolism of thyroid hormones [6–18]. The syndrome manifests in
infants as early as two months of age. It is characterized by truncal
hypotonia evolving into spastic quadriplegia, mental retardation
with severe global developmental delay, dystonic movements, lack
of speech development and other signs of neurological impair-
ment. The defective transport of thyroid hormones across cell
membranes also causes decreased serum concentrations of T4 and
3,3’,5’-triiodothyronine (reverse T3, rT3), and increased T3 by a
complex mechanism involving hormone secretion, metabolism
and excretion [11,14,19–21].
It is assumed that the neurological impairment is due to severe
thyroid hormone deprivation to neurons during a critical phase of
development. In agreement with brain hypothyroidism is the
finding of delayed myelination on magnetic resonance imaging
[13,16]. In vivo 1H nuclear magnetic resonance (NMR) spectros-
copy has also shown altered choline and N-acetylaspartate
concentrations similar to those found in congenital hypothyroid-
ism [18]. However, the clinical picture of MCT8 gene mutations
does not resemble other conditions due to profound thyroid
hormone deficiency during development. For example, neurolog-
ical cretinism is characterized by mental retardation, deafness and
deaf mutism, pyramidal and extrapyramidal dysfunction, and a
specific gait disorder [22,23]. This contrasts with the essential
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features of patients with MCT8 mutations, which according to
Schwartz and Stevenson [17] are ‘‘congenital hypotonia, severe
cognitive impairment, muscle weakness and abnormal hand
positioning.’’ The underlying mechanism of neuronal damage in
MCT8 mutations remains unknown. In particular, in the cellular
contexts, MCT8 may perform some functions besides thyroid
hormone transport [24].
In contrast to the severe neurological impairment of patients
with MCT8 mutations, only some changes of performance in
some behavioral tests have been reported in Mct8KO mice [25].
Mct8 inactivation in mice reproduces the changes of circulating
thyroid hormone concentrations observed in the patients, and
brain T3 content is reduced [26,27]. However the mice do not
present structural changes in brain that might indicate hypothy-
roidism. In addition, the expression of most thyroid hormone-
dependent genes in the cerebral cortex is normal with only a few
exceptions [28]. Differences between the human and mouse
phenotypes might be due to differences in expression of the specific
T4 transporter OATP1C1/Oatp1c1 [29], which is expressed in
the mouse brain capillaries and plasma membrane of the astrocytic
end-feet [5], but has low expression in primates [30]. Oatp1c1
would allow T4 transport through the mouse BBB, even in the
absence of Mct8, leading to the production of local brain T3 by the
type 2 deiodinase (D2), thus preventing Central Nervous System
damage.
Still, the impact of Mct8 inactivation on brain metabolism and
neurotransmitter balance has not been analyzed. In the present
work we performed metabolic studies in the brain of Mct8KO mice
using 13C NMR spectroscopy. This approach provides compre-
hensive information on cerebral energetics and metabolism [31].
In particular, 13C NMR spectroscopy determination of the 13C
label incorporated in relevant carbons of glutamate, glutamine and
GABA after (1-13C) glucose infusions was shown to reveal the
activities of the cerebral tricarboxylic acid (TCA) cycles and the
transcellular glutamate-glutamine and glutamate-GABA cycles
[32]. We have used Mct8KO mice with deficient T3 transport to the
brain [26], and mice with disruption of the D2 gene (D2KO) and
therefore unable to generate T3 from T4 locally in the brain [33].
Data were compared with those from mice made hypothyroid or
hyperthyroid by pharmacological means. We found that the
Mct8KO mice present paradoxical metabolic alterations that
cannot be explained solely by deficiency or excess of thyroid
hormone supply to the brain.
Methods
Ethics Statement
All experimental procedures involving animals were performed
following the European Union Council guidelines (directive 2010/
63/UE) and Spanish regulations (R.D.1201/2005, and Law 32/
2007), and were approved by the Subcommittee on Bioethics of
the Consejo Superior de Investigaciones Cientı´ficas (CSIC) with
the approval reference numbers SAF2008-01168 and SAF2011-
25608. All efforts were made to minimize suffering. Anesthetics
were used as indicated.
Chemicals
(1-13C) glucose (99% 13C) was obtained from Cambridge
Isotope Laboratories (Andover, MA, USA). 2H2O (99.9%
2H)
was acquired from Apollo Scientific Ltd. (Stockport, Cheshire,
UK). All the other items were of the highest purity available
commercially from Sigma-Aldrich (Madrid, Spain).
Animals and genotypes
All experiments were performed with animals 6–7 months of
age. Animals were housed under temperature (2262uC) and light
(12:12 light-dark cycle; lights on at 7 a.m.) controlled conditions
and had free access to food and water. Mct8KO (genotype Mct82/y)
mice were generated by Dumitrescu et al [26] using homologous
recombination. Experiments were carried out on WT and KO
male litter mates derived from heterozygous females crossed with
WT males of the C57BL/6J strain. Genotypes were confirmed by
PCR of tail DNA (38 cycles at 61uC annealing temperature) using
the following primers: Forward common: 5’-ACAGAG-
CAAGTTCCAAGACA-3’; reverse WT-specific: 3’-ATA-
GAAATCAGGCTTGGGAG-5’; reverse KO-specific: 3’-
TTTGTCCTTACGCTGCTCTC-5’. Using this procedure, the
WT allele generated a 573 base pairs (bp) PCR product and the
null allele a 325 bp product. Male mice deficient in D2 (D2KO;
genotype D22/2) [33] were crossed with Mct8-deficient hetero-
zygous females (genotype Mct8+/2) to obtain mice deficient in both
D2 and Mct8 (Mct8D2KO; genotype Mct82/yD22/2). To produce
the male mice used in the experiments female Mct8+/2D22/2
were mated with male Mct82/yD22/2 mice, producing Mct8+/
yD22/2 (D2KO) and Mct82/yD22/2 (Mct8D2KO) male littermates.
The D2KO genotype was confirmed by PCR of tail DNA (38 cycles
at 62uC annealing temperature) using the following primers:
Reverse common: 59- GTTTAGTCATGGAAGCAGCAC-
TATG-3 forward WT-specific: 59- CATGGCGTTAGC-
CAAAACTCATC-39; forward KO-specific: 59- CGTGGGAT-
CATTGTTTTTCTCTTG-39. The procedure generates a
400 bp fragment from the WT allele and a 450 bp fragment
from the null allele.
Induction of hypothyroidism and hyperthyroidism
Hypothyroidism was induced in adult male WT and Mct8KO
mice by administering 0.02% 1-methyl-2-mercapto-imidazol
(MMI, Sigma Chemical Co, St Louis, MO) plus 1% KClO4 ad
libitum in the drinking water for 50 days before sacrifice.
Hyperthyroidism was induced in WT mice by administering
10 mg T3/100 g BW daily in the drinking water, for the 9 days
prior to sacrifice. Since this high dose of T3 was expected to
suppress TSH and thyroid secretions, the mice received also in the
drinking water a physiological dose of T4, 2 mg/100 g BW to
maintain T4 concentrations within normal levels. The rational for
this schedule was to keep normal T4 concentrations in the face of
T3-induced hyperthyroidism, thus maintaining regulatory events
due to extra genomic actions of T4 [34] or related to T4 to T3
conversion by D2 activity [35] This protocol has been validated
earlier in experiments involving WT and D3KO mice. The mice
treated in this way have highly increased T3 concentrations but
normal T4, and unchanged brain D2 activity [36]. In all cases
mice were killed between 9 a.m. to 12 a.m. after an intraperitoneal
injection of a mixture of ketamine 100 mg/kg and medetomidine
0.1 mg/kg).
Measurement of gene expression by quantitative
polymerase chain reaction (qPCR)
The cerebral cortex was rapidly dissected out, frozen on dry ice,
and kept at 280uC until RNA isolation using the Trizol procedure
(Invitrogen, Carlsbad, CA). Complementary DNA was prepared
from 250 ng of RNA using the High Capacity cDNA Reverse
Transcription kit (Applied Biosystems, Foster City, CA). PCR was
performed using a cDNA aliquot synthesized from 5 ng of RNA,
with Taqman primers for Hr (hairless) and D1 (type 1 deiodinase)
and the Taqman Universal PCR Master Mix, No Amp Erase
Brain Metabolism in Mct8-Deficient Mice
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UNG (Applied Biosystems) on a 7900HT Fast Real-Time PCR
System (Applied Biosystems). The PCR program consisted in a hot
start of 95uC for 10 min, followed by 40 cycles of 15 sec at 95uC
and 1 min at 60uC. PCRs were performed in triplicates, using the
18S gene as internal standard and the 22DDCt method for analysis.
Infusion protocol and extracts preparation for NMR
spectroscopy
Mice were deeply anesthetized with 1–2% isoflurane in 1 L
min21 O2 through a nose cap, and infused through the jugular
with (1-13C) glucose (8 mmol min21 g21) during 30 min. The
physiological condition of the animal was followed throughout the
experiment. Respiratory rate was monitored by a Biotrig system
(Bruker Medical GmbH, Ettlingen, Germany), and body temper-
ature was recorded using a rectal probe (Panlab, Barcelona,
Spain). Body temperature was maintained at approximately 37uC
using a thermostatic blanket and a temperature-regulated circu-
lating water bath. At the end of infusion, brain metabolism was
immediately stopped in situ by using a 5-kW microwave fixation
system (Muromachi Kikai Co. Ltd., Tokyo, Japan). The brains
were then rapidly removed from the skull and immediately frozen
in liquid nitrogen. Perchloric acid extracts were prepared from the
individual brains, neutralized with KOH, lyophilized, and
resuspended in 99.9% 2H2O, as described previously [37,38],
prior to performing high-resolution 13C NMR spectroscopy.
13C Nuclear Magnetic Resonance Spectroscopy
High-resolution proton-decoupled 13C NMR spectra of brain
extracts were obtained at 11.9 T (125.13 MHz, 25uC, pH 7.2)
with a Bruker AVANCE 500WB NMR spectrometer using a
commercial (5 mm) triple resonance probe (1H, 13C, 2H)
optimized for direct 13C NMR detection. The acquisition
conditions were: p/3 pulses; 30.0 kHz spectral width; 1.09 s
acquisition time; 64k words data table; and 6.0 s recycling time.
Proton decoupling was only gated during the acquisition using a
broad band composite pulse decoupling sequence, and chemical
shifts were calibrated with an external reference of dioxane (10%
v/v, 67.4 ppm). Resonance assignments were based on literature
values and on the addition of internal standards [37]. Spectra
deconvolution and multiplet structures were analyzed using the
PC-based (Intel Centrino Platform) NMR program, NUTSTM
(Acorn, Freemont, CA).
The absolute amount of 13C incorporated in the different
carbons was determined by comparison of the area of the
corresponding 13C resonances with the unchanged myo-inositol
resonance areas of each one of the perchloric acid extracts [39,40].
This was possible since myo-inositol had a low turnover and did not
become enriched after a 30 min (1-13C) glucose infusion indepen-
dently of the thyroid status [38], providing a robust internal
reference from which all 13C enrichments can be derived. The
absolute amount of 13C incorporation in the different carbons and
the fractional enrichment was determined as previously described
[41,42].
Other procedures
The amino acid content of brain extracts was determined with
an automatic amino acid analyzer Biochrom 20 (Pharmacia,
Uppsala, Sweden) using a cationic exchange column and
precolumn derivatization with ninhydrin [43]. Thyroid hormone
determinations were performed as described [44]. Statistical
calculations were performed using the Graph-Pad Prism software
(http://www.graphpad.com/prism/).
Results
Disruption of the Mct8 gene leads to metabolic changes
in the brain suggesting hyperthyroidism
To correlate the lack of Mct8 with altered thyroid hormone
transport to the brain we compared the metabolic changes caused
by the lack of a functional Mct8 protein with situations of thyroid
hormone deficiency or excess. Our approach was to measure
whole brain metabolism by 13C NMR spectroscopy using (1-13C)
glucose as substrate. Thyroid hormones are involved in the
developmental timing of expression of many enzymes of interme-
diary metabolism and in neurotransmitter systems [2] during the
postnatal period. Neonatal hypothyroidism causes a delay in many
cellular and molecular events, for example expression of myelin
genes, which are then normalized in matured animals. Therefore
in this study we used adult animals to detect permanent changes
induced by Mct8 deficiency.
First we compared Mct8 mutant mice with WT littermates and
with hypothyroid mice of the same genotypes. Hypothyroidism
was induced by treatment with the antithyroid compounds MMI
and KClO4 which efficiently block thyroid hormone biosynthesis
and produce general hypothyroidism. To assess the thyroidal
status of the different groups of mice we measured serum T3 and
the expression of 2 sensitive thyroid hormone target genes, D1 in
the liver and Hr in the cerebral cortex (Fig. 1A). Two-way
ANOVA indicated a significant effect of genotype on serum T3
(P= 0.0045), which increased by around 100% in the Mct8KO
mice. Antithyroid treatment lead also to significant changes of T3
(P= 0.00049), which decreased by around 50% in mice of both
genotypes. Although serum T4 was not measured in these animals,
similar groups showed the characteristic 30–50% reduction of T4
in the Mct8KO mice [26,27,45–47], and 85% reduction in the
hypothyroid mice (not shown). There was a significant effect of
genotype (P= 0.0023) and antithyroid drug treatment (P,0.0001)
on D1 expression, with an increase in the Mct8KO mice and a
pronounced decrease in the hypothyroid mice of the two
genotypes. As for Hr expression in the cerebral cortex, there was
a significant effect of genotype, with a decrease in the Mct8KO
mice (P= 0.0028), but no effect of treatment (P= 0.196).
Fig. 2A shows the effects of Mct8 gene disruption and
antithyroid treatment on the 13C fractional incorporation into
glutamate C4, glutamine C4, and GABA C2 after infusion of
(1-13C) glucose. There was a significant effect of genotype on the
fractional enrichment of 13C into glutamate C4 (P,0.0001),
glutamine C4 (P= 0.00275), and GABA C2 (P,0.0001), with
increases in 13C labeling of the three metabolites in the mutant
mice. Antithyroid treatment also led to differences in glutamate C4
(P,0.0001), glutamine C4 (P,0.0001), and GABA C2
(P= 0.0357) enrichments, which were mainly due to effects of
hypothyroidism on the Mct8KO mice. The interaction between
genotype and treatment was significant, indicating that mice from
each genotype responded differently to antithyroid treatment.
Treatment of WT mice with antithyroid drugs increased 13C
incorporation into the GABA pool without affecting the glutamate
or glutamine pools (Table 1, experiment 1). The same treatment
was very effective on the Mct8KO mice, with a reduction in the
incorporation of 13C into all metabolites, which were now similar
values of WT mice. There was no difference in amino acids
concentrations in the brain extracts (Table 1, experiment 1). In an
attempt to define at the molecular level the mechanisms for these
changes we measured the expression of relevant enzymes by
qPCR: no effects of Mct8 gene inactivation or of hypothyroidism
were found on the expression of Gad1 (glutamate decarboxylase),
Glud1 (glutamate dehydrogenase), Atp1a3 (Na+K+-ATPase), Gls
Brain Metabolism in Mct8-Deficient Mice
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(glutaminase), Glul (glutamine synthetase), and Gabat (GABA
transaminase), nor we found differences in the relative content
of both forms of glutamate decarboxylase (GAD65 and GAD67)
by western blotting (data not shown).
Assuming that the metabolic changes in the Mct8 mutant mice
were due to thyroid hormone deficiency in the brain, in agreement
with the deficient T3 transport and the decreased Hr expression, it
was difficult to explain why they were normalized by blocking
thyroid hormone synthesis. Paradoxically, the results rather
seemed to indicate that the metabolic alterations in the brain of
the Mct8KO mice were due to excess thyroid hormone.
Effects of hyperthyroidism and of D2 inactivation
Prompted by the above results we next evaluated the effect of
hyperthyroidism. Hyperthyroid WT mice were produced by
treatment with high doses of T3 and a physiological dose of T4
for several days. This treatment led to a 6-fold increase of
circulating T3 and normal concentrations of T4 (Fig. 1B). In
agreement with the increased circulating T3, liver D1 and cerebral
cortex Hr expression were increased in the hyperthyroid mice 3-
and 6-fold respectively. As shown in Fig. 2B, again the Mct8KO
mice showed increased 13C fractional incorporation into glutamate
C4, glutamine C4 and GABA C2. Hyperthyroidism increased 13C
incorporation into glutamine, but had no effect on glutamate or
GABA. Therefore, the changes induced by the absence of a
functional Mct8 were not replicated in the hyperthyroid mice.
There was no effect of hyperthyroidism on amino acids
concentrations (Table 1, experiment 2).
In parallel to the effect of hyperthyroidism we also evaluated the
effect of inactivating the D2 gene. D2 is an astrocytic enzyme that
generates T3 from T4. The activity of this enzyme is increased in
the brain of the Mct8KO mice, and partially compensates for the
lack of T3 uptake from the circulation [26,27]. We have previously
shown that D2 gene inactivation in the Mct8KO mice induces a
state of brain hypothyroidism on P21 similar to thyroid hormone
deprivation [28]. To analyze the possible contribution of increased
T3 production from T4 in the brain from Mct8KO mice we
included in the study the mice deficient in D2 (D22/2), and the
double knockout mice for Mct8 and D2 (Mct82/yD22/2). Absence
of D2 increased incorporation of 13C into glutamine but had no
effect on glutamate and GABA. In mice deficient in Mct8 and D2
there was increased 13C incorporation into glutamate C4 and
GABA C2, as in the Mct8KO. It was noteworthy that 13C labeling
in glutamine C4 was not detected in these mice. Again, there was
no difference in amino acids concentrations in the brain extracts
(Table 1, experiment 2).
Discussion
Previous studies on the effects of hypothyroidism on brain
metabolism using NMR spectroscopy have been done in adult and
neonatal rats. Adult onset hypothyroidism decreased metabolism
of (1,2-13C2) acetate, and reduced the incorporation of the label
into cerebral metabolites [38], indicating that hypothyroidism
reduced the consumption of acetate by the glial cycle, and reduced
its metabolism in the glial and neuronal TCA cycles. More
recently, Martinez et al. [48] have also found that neonatal
hypothyroidism decreases the flux of glucose into the glutamate,
glutamine and GABA pools. In agreement with a depression of
cerebral metabolism by hypothyroidism, phosphofructokinase and
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pyruvate kinase activities decrease in the cerebral hemispheres and
cerebellum of hypothyroid rats [49].
In contrast, we found that disruption of the Mct8 gene induces a
generalized increased of neuronal metabolism. 13C incorporation
from glucose to the glutamate, glutamine, and GABA pools was
increased, without changes in absolute pool values. Glutamatergic
activity appears to be coupled to glucose oxidation. Therefore, the
data revealed an increased neuronal glucose oxidation through the
TCA cycle. Thyroid hormone deprivation of the mutant mice
normalized the altered parameters, suggesting that the alterations
of brain metabolism were a consequence of excess of thyroid
hormones. Indeed, some behavioral traits of Mct8KO mice have
been recently interpreted as signs of brain hyperthyroidism [25].
However, this interpretation is difficult to reconcile with what is
known on the thyroid status of the brain of Mct8KO mice. The
brain of these animals is in a state of hypothyroidism partially
compensated by increased local production of T3 due to the
elevated activity of D2 [26–28]. This is the reason why on P21
most thyroid hormone dependent genes have normal expression in
the cerebral cortex, with a few exceptions, including Hr, a sensitive
marker of thyroid hormone action. In the present study we found
that the expression of Hr was also decreased in the Mct8KO mice,
in agreement with previous findings [28,45].
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Table 1. Amino acids concentrations in brain extracts (mmol
g21 wet weight).
Glutamate Glutamine GABA
Experiment 1
WT (6) 6.3560.80 3.1560.72 1.3260.15
Mct8KO (6) 6.6060.35 3.5260.72 1.5160.27
WT Hypo (5) 5.9760.89 2.9060.25 1.2560.16
Mct8KO Hypo (5) 6.5560.95 3.3060.12 1.4060.34
Experiment 2
WT (6) 5.8361.12 2.6660.54 1.2660.23
Mct8KO (4) 6.5661.23 3.6060.78 1.4060.34
WT Hyper (6) 6.2560.45 3.3660.65 1.3860.11
D2KO (4) 6.6660.49 3.2360.90 1.2960.22
Mct8D2KO (4) 5.9460.67 3.4361.01 1.3460.19
The number of animals is given in the first column after the genotypes.
Data are mean 6 SEM.
doi:10.1371/journal.pone.0074621.t001
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It is known that tissues other than the brain are in a
hyperthyroid state in Mct8KO mice. It might be possible that
extracerebral, mainly hepatic (1-13C) glucose metabolism have
contributed to the changes observed in the brain. However,
extracerebral glucose metabolism (mainly hepatic) would generate
mainly (3-13C) lactate, (3-13C) alanine or 13C labeled amino acids.
The permeability of these secondary metabolites through the BBB
is known to be smaller than that of (1-13C) glucose. At the high
(1-13C) glucose concentrations used in our study it is safe to
maintain that the 13C NMR results are dominated by the cerebral
metabolism of (1-13C) glucose and that extracerebral sources of
(3-13C) lactate and 13C amino acids do not contribute appreciably
to the 13C patterns observed. It is also unlikely that the changes
observed are secondary to changes in expression of glucose
transporters, since at the high (1-13C) glucose concentrations used,
glucose metabolism in the brain is known not to be limited by the
transport capacity.
On the other hand, the metabolic changes induced by Mct8
deficiency are different from those observed after inducing
hyperthyroidism by pharmacological means. Hyperthyroidism
increased the 13C fractional incorporation into glutamine C4,
but not into glutamate C4 and GABA C2 as in the Mct8KO. On
the other hand, disruption of the D2 gene did not alter the
metabolic flux through glutamatergic and GABAergic neurotrans-
missions. D2 encodes an enzyme responsible for the local
production of T3 from T4 in brain. Under normal conditions,
this pathway provides around 50% of brain T3. In mice with D2
deficiency, T3 from the circulation is enough to compensate the
expression of many thyroid hormone-dependent genes. However,
since the uptake of circulating T3 depends on the normal
expression of Mct8, absence of both, D2 and Mct8 as in the
Mct8D2KO mice, results in brain hypothyroidism [28]. In this
situation, we found that the changes of glutamate and GABA 13C
labeling were the same as in the single Mct8 deficiency. These
results reduce the possibility that the lack of Mct8 would have
produced an increased T3 production through D2 activity
responsible for the metabolic changes.
At present we lack a mechanistic explanation for many of the
effects of Mct8 inactivation or of other genetic manipulations such
as the increased glutamine C4 in the D2KO, or its lack of detection
in the Mct8D2KO mice. The molecular and cellular bases of the
effects of Mct8 inactivation remain to be clarified. Despite this, it is
clear that the metabolic changes induced by Mct8 deficiency in the
brain could not be correlated with the overall deficiency or excess
of thyroid hormone supply to brain. We do not favor the
explanation that Mct8 might perform thyroid hormone-indepen-
dent actions in the brain [24]. For example, the possibility that
Mct8 could transport a hitherto unidentified metabolite, important
for brain metabolism, seems unlikely in view of the narrow
substrate specificity of Mct8 [50].
The adult Mct8KO mice studied in this work might actually
display a more pronounced brain hypothyroidism than that
attained by adult onset antithyroid treatment of the WT mice.
Indeed, Hr, a very sensitive T3 target gene was altered in the brain
of adult Mct8KO mice and not in the adult hypothyroid WT mice.
This is in agreement with the lower sensitivity of the adult brain in
comparison to the postnatal brain, to hypothyroidism-related
changes of gene expression [51]. (This study described the results
of microarray analysis of the adult rat striatum comparing
hypothyroid rats with hypothyroid rats treated with T3, either in
Figure 3. Thyroid hormone transport and metabolism, and neurotransmitter cycling in astrocytes and neurons. T4 crosses the blood-
brain barrier and is delivered to the astrocytes through the Oatp1c1 transporter, a 12-transmembrane protein localized in the micro capillary
endothelial cells, and in the astrocytic end-feet. Astrocytes express the type 2 deiodinase (D2), localized in the endoplasmic reticulum. This enzyme
catalyzes the phenolic ring deiodination of T4 to produce the active hormone T3. T3 acts genomically on astrocytes and neurons. The transporters
facilitating the passage of T3 from astrocytes to neurons have not been defined. Most likely they consist of a combinatorial mixture of different
transporters depending upon age and cell type. T3 and T4 cross the blood-brain barrier through Mct8, reaching the neurons from the interstitial fluid
through Mct8, and possibly by other transporters. Neurons express the type 3 deiodinase (D3) a plasma membrane protein, which catalyzes the
tyrosil ring deiodination of T4 and T3 to produce the inactive metabolites rT3 and T2, respectively. In astrocytes and neurons, glutamate is produced in
the TCA cycle after glycolysis. Astrocytes can also use the lactate produced by neurons as substrate. Astrocyes express the enzyme glutamine
synthetase (GS), which produces glutamine from glutamate. Neurons express the phosphate-activated glutaminase (GLS), which converts glutamine
back to glutamate. In GABAergic neurons the enzyme glutamic acid decarboxylase (GAD) converts glutamate to GABA. GABA is degraded in
astrocytes and neurons by GABA transaminase (GABA-T), with the formation of succinic acid semialdehyde. This metabolite enters the TCA cycle after
conversion to succinic acid by succinic semialdehyde dehydrogenase (SSADH). Membrane transporters for glucose and neurotransmitters have not
been added for clarity.
doi:10.1371/journal.pone.0074621.g003
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a high single dose (SD) to induce hyperthyroidism, or with daily
replacement doses (RD) to reach euthyroidism. Whereas the SD
treatment resulted in expression changes of many genes, the result
of RD treatment was modest. In particular Hr expression was
increased in the SD groups and did not change in the RD groups.
These experiments were compatible with the view that the adult
rat striatum is more responsive to hyperthyroidism than to
hypothyroidism in terms of gene expression). The Mct8 deficiency
in the Mct8KO mice was present from early embryonic stages in
contrast to the adult-onset hypo or hyperthyroidism in the WT
used for comparison. Brain responses to thyroid hormones may
have been altered permanently in the Mct8KO mice, which show
signs of T3 deficiency and excess at different stages of life [25–
27,46]. Therefore, it is possible that the lack of Mct8 might have
triggered a compensatory increase of brain metabolism as a
response to the sustained hyperthyroidism in the liver and other
tissues or to the chronic impairment of T3 uptake in the brain.
Further investigation into the molecular mechanisms for this
metabolic response will be important to define the physiopathol-
ogy of the brain alterations present in MCT8 deficiency.
Finally, figure 3 illustrates the parallelisms between thyroid
hormone and neurotransmitter transport and metabolism, indi-
cating specifically the cooperation between astrocytes and neurons
in both processes. In late postnatal and adult WT mice, about 50%
of the T3 present in the brain parenchyma originates in the
astrocytes by the D2-catalyzed phenolic ring deiodination [33].
The rest of brain T3 mostly enters the brain from the circulation
through Mct8 present in the BBB. Thyroid hormones may also
reach the brain parenchyma in limited amounts through the
cerebrospinal fluid [52]. On the other hand, circulating T4 crosses
the BBB through the specific T4 transporter Oatp1c1, in addition
to Mct8. Oatp1c1 is also present in the astrocytic end-feet,
facilitating direct delivery of T4 to the D2-expressing astrocytes. In
Mct8KO animals, the absence of T3 transport through the BBB is
compensated by an increased production of T3 from T4 in the
astrocytes. The absence of Mct8 apparently does not result in the
restriction of astrocytic T3 delivery to neurons possibly through
alternative transporters [28]. However, as shown in this paper, the
absence of Mct8 leads to dramatic alterations of neurotransmitter
metabolism, with increased cycling of glutamate, glutamine, and
GABA. At present, it is uncertain whether this is a consequence of
the changes in the T4 and T3 cellular fluxes brought about by the
absence of Mct8-mediated transport, and/or whether they are
related to changes in the expression of enzymes. Indeed, changes
in the intercellular flux of T3 caused by D2 deficiency lead to
selective changes in genes regulated negatively by thyroid
hormone by as yet unknown mechanisms [28,36]. On the other
hand we failed to detect changes in Gls, Atp1a3, Glud1, Gad1, Glul,
and Gabat expression using the whole cerebral cortex, but changes
affecting in a restrictive fashion specific cell groups or regions
cannot be discarded. In relation to the increased rate of GABA
production, it is worth mentioning that succinic semialdehyde
dehydrogenase (SSADH) deficiency in humans and mice, with
accumulation of GABA and gamma-hydroxybutyrate (GHB)
causes severe neurodevelopmental impairment [53]. Whether an
increased GABA cycling contributes to the phenotypic manifes-
tations of MCT8 deficiency in humans is an intriguing possibility
deserving further exploration.
In summary, Mct8 deficiency in mice results in profound
alterations of brain metabolism, consisting of increased oxidative
metabolism and neurotransmitter cycling which could not be
correlated with thyroid hormone deficiency or excess. While the
mechanisms leading to this situation are still unclear, these data
could be relevant to explain the physiopathology of the profound
neurological impairment present in MCT8 mutations.
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